~~<i id='3F2CC4C662'><strike id='3F2CC4C662'><tt id='3F2CC4C662'><pre id='3F2CC4C662'></pre></tt></strike></i>~~

Home» knowledge» focus

focus

author：focus 2025-10-04 11:31:20 Page View：61

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Report captures long Covid’s disabling effects and policy challenges
Next article： New air purifier tech could be key to improving indoor air quality

focus

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

First Opinion Podcast: How to protect health care in times of war

Injusttwoweeks,thebrutalityoftheIsrael-Hamasconflicthasshockedtheworld.Butoneofitsmostheartbreakinga

How one medical school became remarkably diverse

ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

Readers discuss the intersection of pregnancy and addiction

MollyFergusonforSTATFirstOpinionisSTAT’splatformforinteresting,illuminating,andmaybeevenprovocativea